Autologous Stem Cells in the Management of Fistulating Perianal Crohn's Disease

NANot yet recruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

May 1, 2026

Study Completion Date

May 1, 2026

Conditions
Fistula in AnoCrohn Disease
Interventions
DEVICE

Harvest and injection of stem cells

Stem cells will be harvested from bone marrow aspirate and injected into the fistula tract The stem cells are the device intervention for this trial and we are looking to assess the procedure of harvesting and injecting the stem cells Patients will undergo study questionnaire: Harvey-Bradshaw Index, perianal Crohn's disease activity index, and Short IBD questionnaire will be administered before surgery and then at 6 weeks, 3 and 6 months after stem cell intervention.

All Listed Sponsors
lead

Oxford University Hospitals NHS Trust

OTHER

NCT06822686 - Autologous Stem Cells in the Management of Fistulating Perianal Crohn's Disease | Biotech Hunter | Biotech Hunter